Due to tumor heterogeneity and IDH1 allele heterozygosity, the ability to detect the mutant sequence in a background of wild-type DNA is required for this assay to be useful in the detection of IDH1 SNVs in tumor samples. The gene discussed is IDH1; the disease is neoplasm.